fbpx

Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
Compounds & libraries eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our Blog

DNA ENCODED LIBRARIES-CDI-CAPABILITIES
ChemDiv proposes design and synthesis of heterocyclic scaffolds for DNA Encoded Libraries-CDI-Capabilities: • Vast diversity of heterocyclic scaffolds• Proprietary ...
Read More
MAY IS HEPATITIS AWARENESS MONTH
Worldwide, 500 million people are estimated to be infected with hepatitis B or C. These viruses kill 1.5 million people a year; 1 in every 3 people has ...
Read More
YOUR OPINION MATTERS
Note from ChemDiv Customer Care.ChemDiv customers and partners love to share their opinion about our services and products. We always appreciate this feedback and take into account customer ...
Read More
Read Our News >

Pharma News

Pfizer says ‘good reason’ to believe in success of anti-viral drug
May 14, 2021
Drug R&D innovation reshaping manufacturing and the CDMO sector
May 14, 2021
Scientists design new drug compound to stop malaria in its tracks
May 14, 2021
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X